Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
New England Journal of Medicine · 25.07.2024 · 391 (4) · 299-310
DOI: 10.1056/nejmoa2401943 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 25.07.2024. Verfasst von Rohit Loomba und 16 weiteren Autor:innen. Beteiligte Einrichtung: From the Metabolic Dysfunction-Associated Steatotic Liver Disease Research Center, Division of Gastroenterology and Hepatology, Department of Medicin…. Hauptthemen laut MEDLINE: Fatty Liver, Glucagon-Like Peptide-2 Receptor, Liver Cirrhosis. Die Arbeit wurde bisher 1051-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Eli Lilly and Company.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Metabolic Dysfunction-Associated Steatotic Liver Disease Research Center, Division of Gastroenterology and Hepatology, Department of Medicine, University of California at San Diego, La Jolla (R.L.), and Pacific…
ORCID-Profile: Rohit Loomba
Förderung
- Eli Lilly and Company
Zitieren
APA
Loomba, R., Hartman, M. L., Lawitz, E. J., Vuppalanchi, R., Boursier, J., Bugianesi, E., Yoneda, M., Behling, C., Cummings, O. W., Tang, Y., Brouwers, B., Robins, D. A., Nikooie, A., Bunck, M. C., Haupt, A., Sanyal, A. J., & SYNERGY-NASH Investigators (2024). Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis. New England Journal of Medicine, 391(4), 299-310. https://doi.org/10.1056/nejmoa2401943
Vancouver
Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, Boursier J, Bugianesi E, et al. Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis. New England Journal of Medicine. 2024;391(4):299-310. doi:10.1056/nejmoa2401943
BibTeX
@article{Loomba2024,
author = {Loomba, Rohit and Hartman, Mark L and Lawitz, Eric J and Vuppalanchi, Raj and Boursier, Jérôme and Bugianesi, Elisabetta and Yoneda, Masato and Behling, Cynthia and Cummings, Oscar W and Tang, Yuanyuan and Brouwers, Bram and Robins, Deborah A and Nikooie, Amir and Bunck, Mathijs C and Haupt, Axel and Sanyal, Arun J and SYNERGY-NASH Investigators, SYNERGY-NASH Investigators},
title = {Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {4},
pages = {299--310},
doi = {10.1056/nejmoa2401943}
}
EUVIMED